Are Toray and Birch Hill Equity allowed to know about ....11%-12% efficacy at interim and the 18% group from the phase III Euphrates because they own so much stock?
Pardon me, I'm kind of like "Josher buy Gosher", a lil green and new to these types of News Release Drama tales.
TIA,
Sqr